Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Microbiome Drug Development Summit

27 June 2017 08:00 - 29 June 2017 18:00, Boston, United States


Introduction
Using insight gained from the most successful microbiome organizations across the globe, this forum helps emerging and well established companies discover, develop and deliver new generation of microbiome-based therapeutics.

Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement :

• Scientific Activities- Translating microbiome data into a successful health-care product
• Clinical Activities- Obtaining decisive human data in a safe and timely manner
• Regulatory Activities- Outlining clear regulatory paths that guarantee success
• Financial Activities- Maximising shareholder value and sustaining growth

Being part of Microbiome Drug Development Summit gives you the opportunity to get unprecedented access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma and academia to turn microbiome discoveries of today into patient therapies of the future.

Key Benefits of Attending:

-Identify Druggable Targets for Microbiome-Therapeutic Development
-Use Improved Preclinical Models for Drug Discovery
-Design safe and effective Clinical Trials
-Understand the expanding regulatory framework for Microbiome claims
-Hear Novel Methods in Raising Investment to Accelerate Therapeutics Efforts

Useful links

Venue
Aloft Boston Seaport

Aloft Boston Seaport, 401-403 D Street, Boston, 02210, United States

Organised by
HansonWade
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*